Back to search

Article

<i>Patolakaturohiniyadi Kashayam</i> , exerts anti-steatotic and anti-obesogenic effects via coordinated regulation of lipid metabolism, inflammation, and incretin signalling

2026-07-20

Abstract excerpt

<h4>Background</h4> Metabolic dysfunction is characterized by dysregulated lipid metabolism, lipotoxicity, insulin resistance, and chronic low-grade inflammation, contributing to obesity and metabolic dysfunction-associated steatotic liver disease (MASLD). Multi-target therapeutic strategies that restore lipid homeostasis are of growing interest. Patolakaturohiniyadi Kashayam (PKR), a classical Ayurvedic polyher...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a47bb68f-8c2c-5058-9791-ed158d5c5164
DOI
10.64898/2026.07.14.738366
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
<i>Patolakaturohiniyadi Kashayam</i> , exerts anti-steatotic and anti-obesogenic effects via coordinated regulation of lipid metabolism, inflammation, and incretin signallingDOI 10.64898/2026.07.14.738366
<i>Lodhrasavam</i> modulates liver–adipose–pancreas axis to ameliorate MASLD: Observations from <i>In vitro</i> and <i>in vivo</i> models of hepatic and metabolic dysfunctionSemantic proximity
Totum-448, a polyphenol-rich plant extract, decreases hepatic steatosis and inflammation in diet-induced MASLD miceSemantic proximity
A 1,2,3-Triazole Derivative Mitigates Palmitic Acid-Induced Lipotoxicity Through Coordinated Modulation of Lipogenic, Oxidative, and Inflammatory Pathways in HepG2 CellsSemantic proximity
Totum-448, a polyphenol-rich plant extract, decreases hepatic steatosis and inflammation in diet-induced MASLD miceSemantic proximity
Explore of potential targets and mechanisms of hesperetin in treating metabolic dysfunction-associated steatosis liver disease via network pharmacology and in vitro experimentsSemantic proximity
The Effect of Cardiometabolic Drugs on Non-Alcoholic Fatty Liver Disease (NAFLD), Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD), and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)Semantic proximity
Bioavailable Human Metabolites from TOTUM- 448 (Plant-Based, Polyphenol-Rich Ingredient) Maintain Liver Cell Functionality in a Lipotoxic Context that Drives MASLD OnsetSemantic proximity
Therapeutic Mechanisms of Medicine and Food Homology Formula Xiao-Ke-Yin on Glucolipid Metabolic Dysfunction Revealed by Transcriptomics, Metabolomics and Microbiomics in miceSemantic proximity
Modulation of metabolic, inflammatory, fibrotic and cell death pathways by Resmetirom in metabolic dysfunction-associated steatohepatitis (MASH): A transcriptomic profiling studySemantic proximity
Mechanistic Study of Yang-gan-jie-yu Granules in Treating Postmenopausal Metabolic-Associated Fatty Liver Disease Based on Transcriptomics and Network PharmacologySemantic proximity
PPARα-ERRα crosstalk mitigates metabolic dysfunction-associated steatotic liver disease progressionSemantic proximity
Targeting PKLR and lipogenic enzymes through JNK inhibition to develop a therapeutic strategy for MASLD and MASHSemantic proximity
Select a neighboring publication to make it the new centre.